transparency

Showing 15 posts of 93 posts found.

shutterstock_339308225

UK MPs call for greater action on clinical transparency and trial reporting

October 30, 2018
Manufacturing and Production, Research and Development UK, c linical transparency, clinical trials, pharma, transparency

The UK’s House of Commons Science and Technology Committee has argued in a new report that the failure of clinical …

shutterstock_243110086

Not so crystal clear: The EU’s clinical reporting problem

October 29, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EBM Datalabs, clinical trial transparency, clinical trials, feature, pharma, transparency

With shocking new findings revealing that around half of all clinical trial results in Europe go unreported, Matt Fellows explores …

shutterstock_114045100

African-American enrollment disproportionately high in no-consent trials

October 2, 2018
Manufacturing and Production, Research and Development FDA, clinical trials, pharma, transparency

A new study has revealed that African-American citizens make up a disproportionately high share of participants in US clinical trials …

drop-of-water-702639_960_720

Research into clinical trial transparency shows huge variation in standards

July 28, 2017
Medical Communications, Sales and Marketing Abbott, GSK, biotech, clinical trials, drugs, pharma, pharmaceutical, transparency

A study published in the BMJ displayed the large degree of variation and lack of industry-standard when it comes to …

sanofi_hq_reception_close

Sanofi joins growing list of companies making pricing commitments

May 10, 2017
Medical Communications, Research and Development Sanofi, pricing, transparency

Sanofi has entered an ever-growing list of pharmaceutical companies that are pledging to limit the levels of their price increases …

shutterstock_142740349_resize_3

Educating pharma

October 10, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing educated, funding, medical education, transparency

Originally published in the October issue of Pharmafocus, Sean Murray takes a look at how pharma continues to occupy a key …

c_ssilver-fotolia_ebr_jul_2014

Clinical Trial Transparency

September 8, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trial, clinical trial transparency, transparency

Amid the global political and economic turmoil taking place, one small pharma story got much less attention than it should …

Daiichi Sankyo researchers

Daiichi Sankyo to expand access to clinical trial data

February 3, 2016
Research and Development Daiichi Sankyo, R&D, clinical trials, open access, open data, transparency

Daiichi Sankyo has announced today that it will share clinical trial data to qualified researchers through an online web request …

GSK logo

GSK explains decision to halt payments to doctors

January 8, 2016
Medical Communications, Sales and Marketing GSK, doctor payments, medical education, transparency

GSK has put into practice its pledge to halt payments to doctors to promote its products at medical seminars – …

abpi_logo

Health professionals back transparency of their dealings with pharma

October 12, 2015
Research and Development, Sales and Marketing ABPI, transparency

The majority of doctors, nurses, hospital specialists and pharmacists believe that payments received by healthcare professionals (HCPs) from pharmaceutical companies …

CEP report

Pharma ‘spends €40m to sway EU politicians’

September 2, 2015
Medical Communications EU, European Commission, TTIP, drug policy, lobbying, transparency

The pharma industry has excessive power over EU decision-makers and spends €40 million a year to influence EU drug policy, …

crossroads

After the legal case – where next for pharma industry transparency?

August 26, 2015
Research and Development clinical trial transparency, clinical trials, health research authority, transparency

Even in an industry as litigious as pharma can sometimes be, the recent legal drama that has played out in …

Clinical Trial Transparency – A Personal View

August 24, 2015
Research and Development ABPI, PMCPA, clinical trial transparency, clinical trials, health research authority, transparency

During the time I worked as research, medical and innovation director at the ABPI, between October 2012 and January 2015, …

Health secretary Jeremy Hunt

Doctors ‘face jail over pharma payments’

August 24, 2015
Sales and Marketing ABPI, Jeremy Hunt, NHS, PMCPA, bribery, doctor payments, health secretary, transparency

Healthcare professionals who have inappropriate financial links with pharma companies will face prosecution and up to 10 years in jail, …

Latest content